These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22340395)

  • 21. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.
    Rahiman A; Saver JL; Porter V; Buxton W; McNair N; Razinia T; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2008; 17(1):5-8. PubMed ID: 18190814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack.
    Yeh PS; Lin HJ; Bai CH; Hsieh FI; Ke DS; Li YH;
    Am J Cardiol; 2010 May; 105(10):1490-4. PubMed ID: 20451701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy: views from the experts.
    Easton JD; Diener HC; Bornstein NM; Einhäupl K; Gent M; Kaste M; Sacco RL; Tijssen JG; van Gijn J
    Neurology; 1999; 53(7 Suppl 4):S32-7. PubMed ID: 10532646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a health promotion program on medication adherence to antiplatelet therapy among ischemic stroke patients in Hainan Province, China.
    Su Q; Li C; Long F; Chen B; Wan Z; Wu Y; Dai M; Wang D; Zhang Y; Wang B
    Vascular; 2017 Jun; 25(3):242-248. PubMed ID: 27580820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and safety of antiplatelet therapy in stroke recurrence prevention in patients with liver cirrhosis: a 2-year follow-up study.
    Chen CY; Lee KT; Lee CT; Lai WT; Huang YB
    Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1334-43. PubMed ID: 23080224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
    Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
    Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet therapy in diabetic ischemic stroke patients: associated factors and outcomes.
    Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
    Int J Clin Pharmacol Ther; 2011 Oct; 49(10):605-13. PubMed ID: 21961485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in left-sided infective endocarditis.
    Snygg-Martin U; Rasmussen RV; Hassager C; Bruun NE; Andersson R; Olaison L
    Scand J Infect Dis; 2011 Dec; 43(11-12):899-904. PubMed ID: 21916774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary prevention of ischemic stroke in urban China.
    Wei JW; Wang JG; Huang Y; Liu M; Wu Y; Wong LK; Cheng Y; Xu E; Yang Q; Arima H; Heeley EL; Anderson CS;
    Stroke; 2010 May; 41(5):967-74. PubMed ID: 20224061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of antiplatelet agents for secondary prevention of ischemic stroke in U.S. ambulatory care settings.
    Niska R; Han B
    J Health Care Poor Underserved; 2009 Aug; 20(3):831-9. PubMed ID: 19648709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness of secondary stroke prevention guidelines among neurologists in China: a cross-sectional online survey.
    Wu J; Jia LF; Jia JP
    Chin Med J (Engl); 2012 Jun; 125(11):1867-70. PubMed ID: 22884044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of preceding antiplatelet agents on severity of ischemic stroke in patients with a history of stroke.
    Yamada T; Tanaka E; Kishitani T; Kojima Y; Nakashima D; Kitaoji T; Teramukai S; Nagakane Y
    J Neurol Sci; 2024 Jan; 456():122857. PubMed ID: 38154249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism.
    Kim WJ; Ko Y; Yang MH; Im SH; Park JH; Lee J; Lee J; Han MK; Bae HJ
    Stroke; 2010 Jun; 41(6):1200-4. PubMed ID: 20431078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prestroke Antiplatelet Agents in First-Time Ischemic Stroke Are Related to Subtypes.
    Jung JM; Cha J; Choi J; Eun MY; Seo WK; Oh K; Cho KH; Yu S
    Eur Neurol; 2016; 75(1-2):89-95. PubMed ID: 26863137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.